Abstract

Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a known long noncoding RNA, was reported to play a crucial role in follicular growth and ovarian disease. However, the physiological function of MALAT1 in mouse granulosa cells (mGCs) remains largely unclear. The aims of this study were to determine the biological function and molecular mechanism of MALAT1 in mGCs. We knocked down MALAT1 in mGCs by using siRNA against MALAT1. We found that knockdown of MALAT1 promoted apoptosis and caspase-3/9 activities in mGCs. Enzyme-linked immunosorbent assay demonstrated that knockdown of MALAT1 significantly decreased the production of estradiol (E2) and progesterone (P4) in mGCs. Mechanistically, MALAT1 serves as a competing endogenous RNA (ceRNA) to sponge microRNA-205 (miR-205), thereby facilitating its downstream target of cyclic AMP response element- (CRE-) binding protein 1 (CREB1). Furthermore, CREB1 overexpression or miR-205 downregulation partially recovered the effect of MALAT1 depletion in mGCs. In summary, these findings suggested that MALAT1 regulated apoptosis and estradiol synthesis of mGCs through the miR-205/CREB1 axis.

Highlights

  • It is well known that most ovarian follicles (>99%) in the mammalian ovary undergo atresia and degeneration, and only

  • The results showed that the expression of Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) in early atretic follicles (EAFs) and progressively atretic follicles (PAFs) were significantly lower than those in healthy follicles (HFs) (both P < 0:01; Figure 1(a)), suggesting that MALAT1 might be involved in follicular atresia

  • Growing evidence indicates that the initiation of follicular atresia is mainly due to Granulosa cells (GCs) apoptosis [3, 22, 27]

Read more

Summary

Introduction

It is well known that most ovarian follicles (>99%) in the mammalian ovary undergo atresia and degeneration, and only

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call